Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Portable X-Ray Detector Leverages Dual-Energy at the Bedside

By MedImaging International staff writers
Posted on 24 Sep 2020
A novel X-Ray flat panel detector (FPD) simultaneously provides bone and soft-tissue differentiation images in a single X-ray exposure.

The KA Imaging (Waterloo, Canada) Reveal detector is constructed with a unique triple stacked layer design, which permits spectral decomposition of the X-ray beam, allowing for high quantum efficiency of transmitted photons. The additional energy data enables the removal of motion artifacts and selective removal of the anatomical background, thus enhancing detectability of anatomies of interest and providing radiologists with unobstructed front and lateral views of both soft tissue and bone that are sharp and free of motion artifacts, increasing diagnostic sensitivity.

The retrofittable design is also capable of acquiring very high detective quantum efficiency (DQE) digital radiography images. When combined with dual energy capabilities, high quality images of the lungs and bones can be captured, which aids clinicians in visualization of masses with high sensitivity, fractures, pneumonia, and medical device such as catheters and PICC lines. Soft tissue and bone images are sharp and free of motion artifacts. Reveal is also portable, and can be taken to the bedside of patients, which is critical during these pandemic times.

“Reveal is the ideal retrofit solution as it will fit into any ISO standard size tray. Thanks to this feature, the cost of implementation can be reduced to a fraction of the price; whereas conventional dual exposure dual-energy systems can cost as high as half a million dollars, KA Imaging’s Reveal can be obtained at a quarter of this price,” said Amol Karnick, president and CEO of KA Imaging. “You can simply replace your old detector with Reveal, as it will work with any conventional portable or fixed x-ray source.”

“Recent experiences have shown that testing for viral RNA may not suffice as the only test to confirm or rule out the infection,” said Karim S. Karim, CTO of KA Imaging, on the Reveal’s application for COVID-19 detection. “This is where we can help, as radiological imaging, in some cases, has indicated presence of pulmonary disease even days earlier than PCR testing. Moreover, radiological imaging can follow the progress of COVID induced pneumonia over time, enabling timely decision making about treatment efficacy or need for ventilators.”

Related Links:
KA Imaging


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
Acclarix AX9
New
Mobile Digital C-arm X-Ray System
HHMC-200D
New
Digital Radiography Generator
meX+20BT lite
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.